Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
Rajen Mody(C. S. Mott Children's Hospital), Arlene Naranjo(University of Florida), Collin Van Ryn(University of Florida), Alice L. Yu(Chang Gung University), Wendy B. London(Dana-Farber Cancer Institute), Barry L. Shulkin(St. Jude Children's Research Hospital), Marguerite T. Parisi(University of Washington), Sabah-E-Noor Servaes(Children's Hospital of Philadelphia), Mitchell B. Diccianni(University of California, San Diego), Paul M. Sondel(University of Wisconsin–Madison), Julia Glade Bender(Columbia University Irving Medical Center), John M. Maris(Children's Hospital of Philadelphia), Julie R. Park(University of Washington), Rochelle Bagatell(Children's Hospital of Philadelphia)
Cited by 273Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis